These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

33 related articles for article (PubMed ID: 24154781)

  • 21. Major unanswered questions in the clinical gout field.
    Stamp LK
    Curr Opin Rheumatol; 2017 Mar; 29(2):171-177. PubMed ID: 27926541
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Gout in women.
    McClory J; Said N
    Med Health R I; 2009 Nov; 92(11):363-4, 368. PubMed ID: 19999895
    [No Abstract]   [Full Text] [Related]  

  • 23. [The clinical picture of gout is changing].
    Julkunen H; Konttinen YT
    Duodecim; 2010; 126(12):1477-85. PubMed ID: 20617751
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Gout.
    Rott KT; Agudelo CA
    JAMA; 2003 Jun; 289(21):2857-60. PubMed ID: 12783917
    [No Abstract]   [Full Text] [Related]  

  • 25. Urate-lowering therapy for the management of gout: a summary of 2 Cochrane reviews.
    Kydd AS; Seth R; Buchbinder R; Falzon L; Edwards CJ; van der Heijde DM; Bombardier C
    J Rheumatol Suppl; 2014 Sep; 92():33-41. PubMed ID: 25180126
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Uricosuric agent].
    Ohno I
    Nihon Rinsho; 2008 Apr; 66(4):743-7. PubMed ID: 18409525
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Gout: a comprehensive review.
    Rymal E; Rizzolo D
    JAAPA; 2014 Sep; 27(9):26-31. PubMed ID: 25102078
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [A case of fulminant hepatitis, possibly caused by benzbromarone].
    Suzuki T; Suzuki T; Kimura M; Shinoda M; Fujita T; Miyake N; Yamamoto S; Tashiro K
    Nihon Shokakibyo Gakkai Zasshi; 2001 Apr; 98(4):421-5. PubMed ID: 11400273
    [No Abstract]   [Full Text] [Related]  

  • 29. Benzbromarone: availability for general prescribing in New Zealand (a response to letters by Dr Lance Gravatt onbenzbromarone).
    Day R; Lee H; Graham G; Williams K
    N Z Med J; 2013 Sep; 126(1382):124-6. PubMed ID: 24154781
    [No Abstract]   [Full Text] [Related]  

  • 30. A benefit-risk assessment of benzbromarone in the treatment of gout. Was its withdrawal from the market in the best interest of patients?
    Lee MH; Graham GG; Williams KM; Day RO
    Drug Saf; 2008; 31(8):643-65. PubMed ID: 18636784
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Benzbromarone in the treatment of gout.
    Azevedo VF; Kos IA; Vargas-Santos AB; da Rocha Castelar Pinheiro G; Dos Santos Paiva E
    Adv Rheumatol; 2019 Aug; 59(1):37. PubMed ID: 31391099
    [TBL] [Abstract][Full Text] [Related]  

  • 32. International position paper on the appropriate use of uricosurics with the introduction of lesinurad.
    Jansen TL; Perez-Ruiz F; Tausche AK; Richette P
    Clin Rheumatol; 2018 Dec; 37(12):3159-3165. PubMed ID: 30244431
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Management of hyperuricemia in diabetes].
    Hirai A; Saito Y
    Nihon Rinsho; 1997 Nov; 55 Suppl():781-5. PubMed ID: 9434564
    [No Abstract]   [Full Text] [Related]  

    [Previous]     [New Search]
    of 2.